E. Engidawork et al., Selective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndrome, J NEUR TR-S, (61), 2001, pp. 117-130
The ubiquitin-proteasome proteolytic pathway is involved in an important no
n-lysosomal proteolytic pathway that is responsible for the highly selectiv
e turnover of cellular proteins both under basal metabolic conditions as we
ll as stress. Protein degradation by this pathway is attributed to the 20S
proteasome that forms the catalytic core of the complex. Recently there has
been increasing interest in the proteasome because of its possible role in
neuron degeneration and death. Fetal Down syndrome (DS) neurons were demon
strated to degenerate and undergo apoptosis in vitro. We therefore investig
ated the expression of different proteins involved in this degradative path
way, including subunits of the 20S proteasome, ubiquitinating and deubiquit
inating enzymes, and regulatory subunits of the 26S proteasome in control a
nd DS fetal brains by two-dimensional electrophoresis (2-DE). After 2-DE, a
pproximately 389 protein spots were successfully identified by matrix-assoc
iated laser desorption ionization mass spectroscopy (MALDI-MS) and this was
followed by quantification of twenty three proteins of the pathway. The re
sults indicate that all but two proteins exhibited no apparent alterations
in their pattern of expression. Proteasome zeta chain, an alpha subunit of
the 20S proteasome (P < 0.05) and ubiquitin carboxy-terminal hydrolase T (I
sopeptidase T), a deubiquitinating enzyme (P < 0.001) were significantly in
creased in fetal DS compared to controls. Whilst the expression of proteaso
me iota (n = 9. r = -0.9489, P = 0.0004) and proteasome epsilon (n = 9, r =
-0.7227, P = 0.0311) chains was decreased with age in fetal DS brain, no s
ignificant correlation was obtained in the other proteins with age. The dat
a suggest that such selective upregulation may have relevance to the develo
pmental abnormalities that characterize this disorder.